NO985720D0 - Aerosol legemiddelformuleringer av formoterol - Google Patents

Aerosol legemiddelformuleringer av formoterol

Info

Publication number
NO985720D0
NO985720D0 NO985720A NO985720A NO985720D0 NO 985720 D0 NO985720 D0 NO 985720D0 NO 985720 A NO985720 A NO 985720A NO 985720 A NO985720 A NO 985720A NO 985720 D0 NO985720 D0 NO 985720D0
Authority
NO
Norway
Prior art keywords
formoterol
drug formulations
aerosol drug
aerosol
formulations
Prior art date
Application number
NO985720A
Other languages
English (en)
Other versions
NO985720L (no
NO320403B1 (no
Inventor
Martin J Oliver
Simon G Paling
Philip A Jinks
Sukhbinder K Jaiswal
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO985720(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of NO985720D0 publication Critical patent/NO985720D0/no
Publication of NO985720L publication Critical patent/NO985720L/no
Publication of NO320403B1 publication Critical patent/NO320403B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19985720A 1996-06-11 1998-12-07 Farmasoytisksuspensjonsformulering av formoterol egnet for aerosoladministrering, aerosolleverende anordning og fremgangsmate til fremstilling av aerosolformulering NO320403B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations
PCT/US1997/009471 WO1997047286A1 (en) 1996-06-11 1997-06-02 Medicinal aerosol formulations of formoterol

Publications (3)

Publication Number Publication Date
NO985720D0 true NO985720D0 (no) 1998-12-07
NO985720L NO985720L (no) 1999-02-11
NO320403B1 NO320403B1 (no) 2005-11-28

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985720A NO320403B1 (no) 1996-06-11 1998-12-07 Farmasoytisksuspensjonsformulering av formoterol egnet for aerosoladministrering, aerosolleverende anordning og fremgangsmate til fremstilling av aerosolformulering

Country Status (16)

Country Link
EP (2) EP1400239A1 (no)
JP (1) JP5000793B2 (no)
AR (1) AR009231A1 (no)
AT (1) ATE275940T1 (no)
AU (1) AU726382B2 (no)
CA (1) CA2257841C (no)
DE (1) DE69730723T2 (no)
DK (1) DK0934057T3 (no)
ES (1) ES2229366T3 (no)
GB (1) GB9612297D0 (no)
ID (1) ID19520A (no)
NO (1) NO320403B1 (no)
NZ (1) NZ333202A (no)
PT (1) PT934057E (no)
WO (1) WO1997047286A1 (no)
ZA (1) ZA974546B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
WO2000023065A2 (de) * 1998-10-17 2000-04-27 Boehringer Ingelheim Pharma Kg Lagerfähiges wirkstoffkonzentrat mit formoterol
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
CZ303833B6 (cs) 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
SE0004750D0 (sv) 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
CA2495875C (en) * 2002-08-27 2010-06-22 Schering Corporation Process for producing metered dose inhaler formulations
WO2004110460A1 (en) * 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ，インク． 甲状腺眼症の治療のための方法、組成物及び製剤
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2010253776B2 (en) * 2009-05-29 2015-01-22 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
BR112012007484A2 (pt) * 2009-10-02 2020-06-09 Chiesi Farm Spa formulações aerossóis farmacêuticas de formoterol e dipropionato de beclometasona
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5194990A (en) * 1989-02-23 1990-09-26 Rorer International (Holdings), Inc. Therapeutic aerosol formulations
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
US6503482B1 (en) * 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
NZ243061A (en) * 1991-06-10 1993-09-27 Schering Corp Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
DE69218455T2 (de) * 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
NO985720L (no) 1999-02-11
AR009231A1 (es) 2000-04-12
DE69730723D1 (de) 2004-10-21
PT934057E (pt) 2004-12-31
CA2257841A1 (en) 1997-12-18
JP5000793B2 (ja) 2012-08-15
CA2257841C (en) 2008-05-20
WO1997047286A1 (en) 1997-12-18
DE69730723T2 (de) 2005-10-06
EP0934057B1 (en) 2004-09-15
JP2000513340A (ja) 2000-10-10
EP1400239A1 (en) 2004-03-24
NO320403B1 (no) 2005-11-28
DK0934057T3 (da) 2005-01-24
ID19520A (id) 1998-07-16
NZ333202A (en) 2000-06-23
AU3373997A (en) 1998-01-07
ATE275940T1 (de) 2004-10-15
AU726382B2 (en) 2000-11-02
GB9612297D0 (en) 1996-08-14
EP0934057A1 (en) 1999-08-11
ES2229366T3 (es) 2005-04-16
ZA974546B (en) 1998-11-23

Similar Documents

Publication Publication Date Title
NO985720D0 (no) Aerosol legemiddelformuleringer av formoterol
DE69530325D1 (de) Aerosol-arzneiformulierungen
IT1293803B1 (it) Formulazioni di aerosol medicinali
NO981967L (no) Stabile fryset°rkede farmas°ytiske formuleringer
DK1073417T3 (da) Farmaceutisk aerosolformulering
BR9610153A (pt) Formulações farmacêuticas
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
IS5245A (is) Lyfjablanda úr ómeprasól
ATE320246T1 (de) Medizinische aerosolformulierungen enthaltend budesonide
ITMI961087A0 (it) Distributore di sostanze cremose
ID18832A (id) Komposisi insektisida
ID16781A (id) Formulasi-formulasi farmasi
DK0927037T3 (da) Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
ITMI941169A0 (it) Formulazioni farmaceutiche
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
ID23774A (id) Komposisi insektisida
SE9404469D0 (sv) Aerosol formulations
SE9502453D0 (sv) Drug formulations
SE9502452D0 (sv) Aerosol formulations
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
SE9600141D0 (sv) Pharmaceutical formulation
FI963182A0 (fi) Foerfarande foer tillvaratagning av sterol och xylitol